Methylphenidate ER

Open Solicitation Posted

Solicitation number
SPE2D226R0013
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support seeks a national requirements contract for methylphenidate extended-release tablets in four strengths (18 MG, 27 MG, 36 MG, and 54 MG) in 100-count bottles, with proposals due October 23, 2026, at 3:00 PM ET. This is an unrestricted, fully competitive commercial item acquisition under FAR Part 12.

The contract is firm-fixed-price, requirements-type with a one-year base period and four one-year options. Annual usage estimates are 25,988 bottles (18 MG), 35,111 bottles (36 MG), 25,512 bottles (27 MG), and 18,708 bottles (54 MG). Products will be distributed through pharmaceutical prime vendors (AmerisourceBergen Drug Co., Cardinal Health, DMS Pharmaceutical Group Inc., and McKesson Corp.) to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons.

Technical requirements include FDA approval (NDA/ANDA/BLA), current Good Manufacturing Practices compliance, unit-of-use packaging in plastic bottles with child-proof closures and bar code labeling per GS1-128 or HIBCC standards, and product registration with RXNorm, First Data Bank, and Medi-Span within five days of award. Contractors must submit a cost recovery fee of 0.5 percent of contract sales via quarterly reports and comply with Trade Agreements Act requirements. Large business concerns must submit a subcontracting plan. Evaluation uses lowest-price technically acceptable (LPTA) criteria. Offers must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS). Contact Jeremy Brown at (445) 737-5419 or jeremy.brown@dla.mil for questions.

Notice text

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Methylphenidate ER Tablets. Procurement details follow.
 

Methylphenidate ER 18MG, 27MG, 36MG, and 54MG Tablets in 100 count bottles.

This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.   

Files

File Type Posted
Methylphenidate ER Solicitation final.pdf PDF

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
Methylphenidate ER Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Epinephrine Injector NAICS 325412 Medical Supply Chain No set-aside
Febuxostat Tablets NAICS 325412 Medical Supply Chain No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity